
For years, the healthcare industry in general and oncology practices in specific clung to the fee-for-service approach in billing. And it worked for them pretty well. But now, circumstances have changed. Treatment costs have soared. Delivery systems have become more fragmented. And patient outcomes have become more inconsistent.
This is where value-based care comes in. It is the model to bring fundamental changes in how oncologists, payers, and health systems can form an ecosystem where there is a nice balance between quality treatment provision and reimbursements.
The recent advancements surely have made cancer care more effective and diversified. But they also have brought significant challenges. Treatment drugs have become more expensive and care delivery more complicated. Choosing the right treatment has become more difficult for practitioners and hospitals. The reasons are the following:
These issues raised the need for a dedicated framework that could ensure quality care without creating revenue constraints for providers. Value-based care is that framework.
As mentioned above, VBS focuses on patient care quality. Under this framework, the regulatory bodies promise providers incentives for ensuring quality care. The major quality criteria include patient satisfaction and a reduction in unnecessary visits. There is a stark contrast between both these requirements, which means providers must go in with a balanced treatment strategy.
VBC also adds payers to the loop. But again, the responsibility falls upon the providers to work with their payers in setting goals, formulating payment incentive programs, and tracking the performance of treatment plans.
The top benefits of this model are as under:
The government’s initiative to make healthcare more value-driven is not new. Authorities have been guiding and funding institutions to ensure adoption of value-based care models for many years.
Almost all reimbursement reforms come from CMS. Their particular CMMI program regularly develops and tests payment models that focus on improved care quality at reduced costs. Their initiatives in oncology care include:
Alternative Payment Models (APMs) And Bundled Payments
APM is another model that ties financial risk and reward to the care value. In oncology, this model governs bundled payments, which refer to fixed amounts for entire treatment episodes rather than individual treatments. The particular protocol for such payments is Bundled Payments for Care Improvement (BPCI).
This program is the most comprehensive VBC model. Being a part of the QPP, this program links payments to:
This model uses a specialized scoring system that rates a practice’s performance in all four areas. The practice is then incentivized or penalized based on the mean score.
VBC models are relatively more complex than fee-for-service systems. And in the case of oncology, the complexity can be exponential. The top challenges cancer care centers face in this regard include:
The most effective way to provide value is to streamline your practice and keep your resources intact. A stable revenue stream will help you save enough resources to go through this major shift without disruption.
At AltuMED, we provide expert RCM services that help you achieve your revenue goals. Our financial specialists have particular expertise in MIPS and QPP reporting. And our billing services take the burden off your shoulders so that you can focus more on patient care. That fulfills the crucial requirement for value-based care.
Enter Your Email Address. We Promise We Won't Spam You
Enter your email to receive our newsletter, so you can stay in the loop with our latest promos.